4D Molecular Therapeutics (FDMT) Operating Margin (2020 - 2026)
4D Molecular Therapeutics (FDMT) reported Operating Margin of -2037.16% for Q2 2026, up 394336.17 percentage points from -396373.33% a year earlier and up 378.99 percentage points from the prior quarter.
4D Molecular Therapeutics (FDMT) Operating Margin (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, 4D Molecular Therapeutics' Operating Margin came in at -214.24%, up 667440.31 percentage points year-over-year; for FY2025, it was -187.24%, up 507491.14 percentage points from FY2024.
- Operating Margin has a five-year change of +229.04 percentage points (FY2020 to FY2025).
- By year, Operating Margin came in at -507678.38% in FY2024 (-507133.73 pp), -544.65% in FY2023 (+2971.88 pp), -3516.52% in FY2022 (-3121.06 pp) and -395.46% in FY2021 (+20.82 pp).
- Five-year quarterly Operating Margin spans a low of -5611700.00% in Q4 2024 and a high of 17.29% in Q4 2025.
- Year over year, Operating Margin has now increased in each of the last five quarters, with an average year-over-year change of +932095.69 percentage points over the last seven quarters.
- The high point for year-over-year Operating Margin in five years was Q4 2025 (a gain of 5611717.29 percentage points); the low point was Q3 2024 (a drop of 1704330.84 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -2416.15% (Q1 2026), 17.29% (Q4 2025) and -67983.33% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 28.37% |
| 10 | 4D Molecular Therapeutics | 891.75 Mn | -568.19 Mn | - | -2,037.16% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,037.16% |
| Mar 31, 2026 | -2,416.15% |
| Dec 31, 2025 | 17.29% |
| Sep 30, 2025 | -67,983.33% |
| Jun 30, 2025 | -396,373.33% |
| Mar 31, 2025 | -383,007.14% |
| Dec 31, 2024 | -5,611,700.00% |
| Sep 30, 2024 | -1,704,400.00% |
| Jun 30, 2024 | -849,120.00% |
| Mar 31, 2024 | -136,200.00% |
| Sep 30, 2023 | -69.16% |
| Jun 30, 2023 | -13,446.03% |
| Mar 31, 2023 | -10,102.68% |
| Dec 31, 2022 | -2,303.13% |
| Sep 30, 2022 | -5,299.00% |
| Jun 30, 2022 | -17,546.91% |
| Mar 31, 2022 | -2,165.05% |
| Dec 31, 2021 | -26,917.39% |
| Sep 30, 2021 | -1,658.93% |
| Jun 30, 2021 | -52.10% |
4D Molecular Therapeutics Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();